1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : PHARMACEUTICALS
  4. ZYDUS LIFESCIENCES LTD.
Zydus Lifesciences Ltd.
NSE: ZYDUSLIFE | BSE: 532321
1150.80 -8.20 (-0.71%)
859.7K
NSE+BSE Volume

NSE 10 Jul, 2026 3:57 PM (IST)

Watchlist

Portfolio

Alert

Dividend
Zydus Lifesciences has an upcoming dividend of ₹1.000 per share due on 24 Jul 2026 See details


Board Meetings - Zydus Lifesciences

The latest board meeting for Zydus Lifesciences took place on 19 May 2026, for the purpose of Audited Results, Dividend & Buy Back

Ex-date Purpose Notes
19 May 2026 Audited Results, Dividend & Buy Back -
09 Feb 2026 Quarterly Results -
06 Nov 2025 Quarterly Results & Fund raising Inter-alia, to consider 1. Proposal for raising funds up to Rs. 5,000 Crores through the issuance of eligible securities of the Company by way of qualified institutions placement(s), rights issue or any other method...
12 Aug 2025 Quarterly Results -
20 May 2025 Audited Results & Final Dividend -
05 Feb 2025 Quarterly Results -
12 Nov 2024 Quarterly Results -
09 Aug 2024 Quarterly Results -
17 May 2024 Audited Results & Final Dividend -
09 Feb 2024 Quarterly Results & Buy Back of shares -
07 Nov 2023 Quarterly Results -
11 Aug 2023 Quarterly Results -
18 May 2023 Audited Results & Final Dividend -
03 Feb 2023 Quarterly Results -
11 Nov 2022 Quarterly Results -
10 Aug 2022 Quarterly Results -
20 May 2022 Audited Results, Dividend & Buy Back -
03 Feb 2022 Quarterly Results -
29 Oct 2021 Quarterly Results -
11 Aug 2021 Quarterly Results -
27 May 2021 Audited Results & Final Dividend -
05 Feb 2021 Quarterly Results -
02 Nov 2020 Quarterly Results -
05 Aug 2020 Quarterly Results -
19 Jun 2020 Audited Results -
16 Mar 2020 Interim Dividend -
05 Feb 2020 Quarterly Results -
13 Nov 2019 Quarterly Results -
09 Aug 2019 Quarterly Results -
29 May 2019 Audited Results & Final Dividend -
07 Feb 2019 Quarterly Results -
03 Nov 2018 Quarterly Results -
13 Aug 2018 Quarterly Results -
25 May 2018 Audited Results, Dividend & Others -
08 Feb 2018 Quarterly Results -
14 Nov 2017 Quarterly Results -
11 Aug 2017 Quarterly Results -
26 Jun 2017 Others To raise funds by issue of Equity Shares / Convertible Bonds / Debentures through Qualified Institutional Placement [QIP] / GDR / ADR, subject to approval of the shareholders.
27 May 2017 Audited Results -
07 Mar 2017 Interim Dividend -
31 Jan 2017 Quarterly Results -
17 Nov 2016 Scheme of Arrangement -
26 Oct 2016 Quarterly Results -
03 Aug 2016 Quarterly Results -
13 May 2016 Audited Results & Others To raise funds by issue of Equity Shares / convertible Bonds / Debentures through Qualified Institutional Placement [QIP] / GDR / ADR for an aggregate amount upto Rs.10,000 Crores,
08 Mar 2016 Interim Dividend -
05 Feb 2016 Quarterly Results -
22 Oct 2015 Quarterly Results -
12 Aug 2015 Quarterly Results Approved the sub-division (split) of one equity share of the Company having a face value of Rs.5/- into five equity-shares of face of Rs.1/- each.
15 May 2015 Audited Results & Dividend To delist Equity Shares of the Company from Ahmedabad Stock Exchange Limited (ASE), in view of non-trading of Equity Shares of the Company on ASE since last so many years.
10 Feb 2015 Quarterly Results -
06 Nov 2014 Quarterly Results -
30 Jul 2014 Quarterly Results -
16 May 2014 Audited Results & Dividend -
07 Feb 2014 Quarterly Results -
31 Oct 2013 Quarterly Results -
30 Aug 2013 Audited merged accounts To consider and approve the audited merged accounts for the financial year ended on March 31, 2013.
07 Aug 2013 Quarterly Results -
30 May 2013 Audited Results & Interim Dividend -
22 Apr 2013 Scheme of Amalgamation -
08 Feb 2013 Quarterly Results -
07 Nov 2012 Quarterly Results -
06 Aug 2012 Quarterly Results -
10 May 2012 Audited Results & Dividend -
07 Feb 2012 Quarterly Results -
10 Nov 2011 Quarterly Results -
19 Jul 2011 Quarterly Results -
06 May 2011 Audited Results & Dividend -
18 Jan 2011 Quarterly Results & Others The Board will elect the Chairman of the Investors' Grievance Committee.
19 Oct 2010 Quarterly Results -
27 Jul 2010 Quarterly Results -
29 Apr 2010 Audited Results & Dividend -
25 Feb 2010 Increase the Authorised Capital & Bonus To increase the Authorised Share Capital of the Company from Rs. 700/- Millions to Rs. 1100/- Millions & to issue of Bonus Equity Shares in the ratio 1:2 of Rs. 5/- each fully paid-up Equity Shares.
25 Jan 2010 Quarterly Results -
27 Oct 2009 Quarterly Results -
27 Jul 2009 Quarterly Results -
28 Apr 2009 Audited Results & Dividend -
27 Jan 2009 Quarterly Results -
22 Oct 2008 Quarterly Results -
29 Jul 2008 Quarterly Results -
04 Jul 2008 Composite Scheme of Arrangement To approve the "Composite Scheme of Arrangement between Cadila, Carnation and Zydus Hospitals and Medical Research Pvt Ltd".
17 Jun 2008 To consider Re-structure of CPB To consider options to consolidate / restructure the Consumer Products business of the group, including its listed subsidiary, namely Carnation Nutra-Analogue Foods Ltd.
29 Apr 2008 Audited Results & Dividend -
31 Jan 2008 Quarterly Results -
26 Oct 2007 Quarterly Results -
31 Jul 2007 Quarterly Results -
17 Jun 2007 To consider issue f FCCB's inter alia, to consider, to issue Foreign Currency Convertible Bonds (FCCBs) / ADRs / GDRs, etc. subject to approval of shareholders and such other statutory authorities.
26 Apr 2007 Audited Results & Dividend -
22 Jan 2007 Quarterly Results -
31 Oct 2006 Quarterly Results -
28 Jul 2006 Quarterly Results -
28 Apr 2006 Bonus issue -
28 Jan 2006 Quarterly Results -
22 Oct 2005 Quarterly Results -
26 Jul 2005 Quarterly Results -
29 Apr 2005 Accounts & Dividend -
27 Jan 2005 Quarterly Results -
25 Oct 2004 Quarterly Results -
26 Jul 2004 Quarterly Results -
26 Apr 2004 Dividend & Accounts -